c19early.org COVID-19 treatment researchCetylpyridinium ChlorideCetylpyridin.. (more..)
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta
Thermotherapy Meta
Melatonin Meta
Metformin Meta

Loading...
 
More
 

Supplementary Data — Cetylpyridinium Chloride reduces COVID-19 risk: real-time meta analysis of 4 studies

@CovidAnalysis, October 2025, Version 6V6
0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ Bonn (DB RCT) 85% 0.15 [0.01-2.74] viral load 6 (n) 9 (n) Short term viral CT​1 Improvement, RR [CI] Treatment Control AMPoL Gansky (DB RCT) 60% 0.40 [0.02-7.68] no recov. 0/3 1/6 Ponphaib.. (DB RCT) 36% 0.64 [0.46-0.89] no recov. 25/53 42/57 CT​1 Ponphaib.. (DB RCT) 24% 0.76 [0.64-0.89] no recov. 43/59 55/57 CT​1 Ponphaib.. (DB RCT) 14% 0.86 [0.77-0.97] no recov. 50/59 56/57 CT​1 Ponphaib.. (DB RCT) 30% 0.70 [0.59-0.84] no recov. 40/59 55/57 CT​1 Rengifo (DB RCT) 68% 0.32 [0.01-7.20] hosp. 0/12 1/11 CT​1 Rengifo (DB RCT) 83% 0.17 [0.02-1.20] viral+ 1/12 5/10 CT​1 Cetylpyridinium chloride COVID-19 outcomes c19early.org October 2025 1 CT: study uses combined treatment Favors CPC Favors control
Fig. S1. All outcomes.
Please send us corrections, updates, or comments. c19early involves the extraction of 200,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
  or use drag and drop   
Submit